MedTrace Logo

Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

NCT02632851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2016-06-21

No results posted yet for this study

Summary

This observational, non-interventional multicentric study compares the inhalation therapy on patients suffering on respiratory tract infections and/or acute bronchitis between Ectoin inhalation solution and Pari NaCl (0.9%) inhalation solution

Conditions

  • Bronchitis
  • Cough
  • Sputum, Cellular Atypia
  • Dyspnoea

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • R Mösges, Prof Dr · University of Cologne

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632851 on ClinicalTrials.gov